mesothelioma Cellular Analytics Eyes Early Mesothelioma Detection Using Liquid Biopsy Tech Premium The firm's assay, dubbed MesoFind, uses an immunomagnetic capture method to identify surface antigens on mesothelioma pleural cells in a patient's blood sample. CAR T Cell Therapies Targeting HER2, Mesothelin Show Activity in Solid Tumors Premium In the hunt for an antigen in solid tumors that CAR T cells can target, researchers demonstrate the safety and efficacy profile of two such agents in early studies. MSI Tumor Analysis Implicates Lynch Syndrome in Several New Cancer Types In a pan-cancer analysis, Lynch syndrome genes were mutated more often than anticipated in tumors with high or intermediate levels of microsatellite instability. New Genetic Variant Discovered to Cause Peritoneal Mesothelioma Researchers identified unique ALK rearrangements in patients that lack previously known indicators of mesothelioma. Study IDs Recurrent Mesothelioma Tumor Alterations Genomic and transcriptomic sequence data from hundreds of mesothelioma tumors has uncovered recurrent gene mutations, gene fusions, and pathway alterations. Dec 18, 2014 Castle's Eye Cancer Test Widely Adopted as Firm Anticipates Growth Beyond Niche Cancer Market Premium Sep 4, 2014 ADRI Begins Phase I Trial of microRNA Mimic for Mesothelioma Premium Aug 13, 2014 Cancer MDx Firm Castle Biosciences Raises $11.8M Oct 5, 2012 Somalogic Publishes Validation Study on 13-Protein Dx for Detection of Mesothelioma Premium Sep 12, 2012 Castle Bio Licenses IP from Brigham and Women's Hospital for Mesothelioma Test May 10, 2012 Australian Team Finds Blood miRNA with Potential for Early Diagnosis of Malignant Mesothelioma Premium Jun 16, 2011 Rosetta Signs Marketing Deal for Mesothelioma Test with Tort Claims Administration Firm Premium Jun 14, 2011 Rosetta Genomics, Pace Ally on Mesothelioma Test Marketing, Services Apr 8, 2011 NYU, Somalogic Present Data on Protein Biomarker Test for Mesothelioma Premium Dec 30, 2010 CDC Plans $5M for Mesothelioma Biobank Oct 15, 2010 Somalogic Launches Validation Studies of Protein Biomarkers for Pancreatic Cancer and Mesothelioma Premium Feb 18, 2010 Q&A: NYU Langone Medical Center's Harvey Pass on miR-29c* and Mesothelioma Prognosis Premium Apr 30, 2009 Three RNAi, miRNA Firms Record Strong Gains in Stock Value Since the End of 2008 Premium Apr 30, 2009 Rosetta, Prometheus Close Deal for miRNA Dx Market Rights Premium Apr 16, 2009 Rosetta Grants Prometheus Rights to Sell Suite of microRNA Diagnostics in US Premium Mar 5, 2009 CombiMatrix Aims to Launch miRNA-Based Cancer Screen by Mid-2010 Premium Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.